Comparator Drug Sourcing

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Comparator Drug Sourcing.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Category Alerts


Germany and Denmark collaborate on the integration of hydrogen and energy systems.

March 30, 2023
alert level: Low

Amazon sources Japanese Green Electricity

February 15, 2023
alert level: Low

Australian Price Caps

February 14, 2023
alert level: Medium

Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on Comparator Drug Sourcing

Schedule a Demo

Comparator Drug Sourcing Market Monitoring Dashboard

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Schedule a Demo

Comparator Drug Sourcing Industry Benchmarks

Savings Achieved

(in %)

The average annual savings achieved in Comparator Drug Sourcing category is 8.10%

Payment Terms

(in days)

The industry average payment terms in Comparator Drug Sourcing category for the current quarter is 35.0 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length


Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk



Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi

    Comparator Drug Sourcing market frequently asked questions

    The global comparator drug sourcing market attained a valuation of $0.96 Bn in 2020, and the figure is likely to multiply at 7-7.5 CAGR during 2020-2025.

    As part of their market strategy, global comparator drug sourcing market players are focusing on sourcing comparators and clinical trials from emerging countries at better pricing. In addition, they are tapping into small markets by joining forces with distributors/logistics players who can deliver to different regions with fewer supply bases.

    The COVID-19 pandemic has adversely affected the logistics of trial supplies, from the pre-clinical stage to data analysis. While the crisis has underscored the need for automation, industry growth has slumped by 5-10% due to a limited workforce.

    Innovations in the trial supply chain via e-commerce platforms using artificial intelligence (AI) will enable delivery to multiple locations. Moreover, these platforms allow market players to connect with various distributors for a specific trial supply, including comparators, and examine the suitable distributor.

    Equipping comparator sourcing with AI boosts the operational efficacy and slashes the trial cost by decreasing sourcing overages. Moving ahead, implementing blockchain in pharma supply chain financial service platforms improves visibility, efficiency, and financial operations.

    Several global comparator drug sourcing market players are integrating interactive response technology (IRT) with an electronic data capture (EDC) to improve transparency in clinical operations and the flow of clinical supply. Moreover, fusing IRT with real-time tracking equipment enhances flexibility and makes it easy for medical professionals to monitor patients residing in remote areas.

    Comparator Drug Sourcing market report transcript


    Global Comparator Sourcing Market: $1.02 billion in 2022E​

    Global CAGR: Approx. 7.5–7.8 percent (2021–2026)

    • The global market is expected to be at $1.02 billion in 2022 and will grow at a CAGR of 7.5–7.8 percent between 2021 and 2026

    • Emerging countries in Eastern Europe and Asia Pacific have been evolving in providing comparators and clinical trial supplies, which can cater to the client needs across the globe. Sourcing from emerging countries provide value for the product at better pricing

    • At the same time, global players are reaching small markets by expanding their network with distributors/logistics players, who can deliver to regions with fewer supply base

    Global Market Size and Growth Forecast: Global Comparator Market

    • The CTS market will grow at a CAGR of around 7.5–7.8 percent between 2021 and 2026. Comparators as a service hold approximately 8-10 percent of the CTS market and spend wise occupy 50 percent of the sponsors CTS budget, thus making it one of the major categories to focus so as to reduce cost and time associated with supply delays.

    • Studies being conducted in remote locations and demand for better supply capabilities are driving the market while factors such as shorter shelf life of biologics, differences in sourcing for biosimilars as against branded drugs, counterfeit of comparators restrain the market and force stringent regulatory actions.

    Cost Drivers and Cost Structure

    • Cost of the drug occupies the major share of pie, attributing to the reality of costly innovator drugs, which can be reduced by procuring cost-effective comparators from emerging markets, like India and China.

    • Proactive demand planning in fluctuating patient enrollment while sourcing comparators can reduce destructions costs and shortage of the required quantity.

    Market Trends

    • The COVID-19 pandemic has created the need for automation, but also has resulted in 5-10 percent dip in the industry. This may be due to industries working with limited workforce

    • To improve efficiency in clinical trial processes, to save valuable resources, pharma is automating clinical trial supplies process including sourcing of comparators that includes adopting new technologies in packaging and labelling, printing, use of IRT and RTSM and integrating the solutions for efficient clinical operations

    Use of IRT/RTSM

    • Industry is moving to Integrate IRT systems with EDC to enhance visibility in clinical operations and flow of clinical supply

    • IRT provides access to patient data and on time delivery of drugs to the patient, which increases the efficiency of trial and reduces the cost to trial (reduces overages).

    • Integrating IRT with real-time monitoring devices will increase the flexibility and make it easy for investigators to monitor patients in remote location.

    • Suppliers are actively moving to adopt digital data collection from paper based process.

    AI & Block Chain Technology

    • Applying AI to comparator sourcing will increase operational efficiency and reduces the trial cost by reducing the overages of sourcing

    • Implementing new strategies for waste reduction, including IRT and predictive AI

    • A clinical supply chain management company developed logistics software platform that uses EDC and IRT to actively monitor clinical supply consumption, patient timelines and supply kit expiration

    • Block Chain is being implemented in pharma procurement supply chain financial services platform to improve efficiency, transparency, and financial operations

    • In Africa, mass serialization and blockchain tech(assigning an ID for a product and saving as an asset in the blockchain) is being adapted to reduce counterfeit and illegal supply of drugs

    eLabels & Smart Packaging

    • Integration of technologies, such as eLabels and smart packaging in clinical trial supplies, will increase the real-time monitoring (updating the information of dose, time to take medication, change in protocol number - eLabels) and increase patient adherence to the treatment (smart labels & packaging).

    Shift towards biologics

    • Focus on precision medicine, gene therapies, and oncology therapeutics has significantly contributed to the complexity of bio samples logistics.

    • This has led to increased need for robust and sophisticated cold storage and cold chain supply capabilities with suppliers constantly innovating to fill the gap

    Unmanned aircrafts/Drones in clinical trial supplies

    • Drone technology in clinical trial supplies allows Just-In-Time and Direct to Patient approaches where pharma can distribute medication based on the requirement and usage. This reduces the wastage of trial supplies.

    • A global player has partnered to work on a pilot project to deliver trial supplies to the facilities and also Direct to home kits

    Interesting Reads:

    Discover the world of market intelligence and how it can elevate your business strategies.

    Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.

    Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

    Schedule a Demo Now